ReForm Biologics Bolsters Diversity With New Appointments to Board of Directors

WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, Inc., a company developing a new generation of innovative biologic medicines to improve patient access, safety, and convenience, today announced the appointment of four new Directors with significant life science and biotechnology experience: Roopom Banerjee, Kirsten Flowers, Stuart Randle and Edward Sullivan. “A Board of Directors should reflect a company’s mission, vision, and stage of development. These four new board members will deepen ReFo
Click here to view original post